BriaCell Therapeutics Corp. (BCTX) income statement
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.51+0.21 (+6.36%)
Close on Nov 17, 2026Market cap $30.65MP/E –Yield –
BriaCell Therapeutics Corp. income statement
Ratios
Latest available, balances at Jul 31, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- –
Financial strength
- Current ratio
- 2.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 123.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?